AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC Obesity & Diabetes Meds

AstraZeneca’s deal with CSPC Pharmaceutical Group includes a Phase 1-ready obesity drug that hits the same targets as Eli Lilly’s obesity drug Zepbound, but with monthly dosing. The new collaboration builds on an existing drug R&D relationship between the two companies. The post AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC…

Read More

Prostate Cancer Management – We Need Better Options for Early-Stage Disease

We need to continue investing in research for early stage, localized prostate cancer, develop treatments that balance efficacy with quality-of-life considerations, ensure diverse representation in clinical trials, and listen to patients and incorporate their perspectives into treatment development and decision-making.  The post Prostate Cancer Management – We Need Better Options for Early-Stage Disease appeared first…

Read More

“Will my insurance cover my stay?”

This is a question I can’t answer with certainty. Patients often believe that since I’m part of the health-care system, I would know. But I don’t, not as a doctor — and not even when I’m a patient myself. In the United States, health insurance is so extraordinarily complicated, with different insurers offering different plans,…

Read More

Monkeypox : Symptoms, Causes, Diagnosis & Treatment

WHO has declared monkeypox or Mpox a global emergency and pandemic, given the recent outbreak in multiple countries across the world. The Mpox virus is native to Africa, but 2022-2023 has seen Mpox outbreaks in more than 110 countries. A highly infectious disease, Mpox has already infected over 1 lakh people and has already claimed…

Read More